FGFR2 and intrahepatic cholangiocarcinoma: To assess the function of novel fusions identified in our ICC specimens and determine their responsiveness to FGFR2-targeted drugs, we constructed expression vectors of these fusions and labeled them with FLAG epitope tag (Supplementary Fig. 1).